Community acquired pneumococcal pneumonia in hospitalized adult patients;Neumonía neumocócica adquirida en la comunidad en adultos hospitalizados

Revista Medica de Chile

Volumn 131, Issue 5, 2003, Pages 505-514

  Díaz F, Alejandro ^a   Torres M, Catalina ^a   Flores S, Luis José ^a   García C, Patricia ^a   Saldías P, Fernando ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Hospital mortality; Pneumonia, pneumococcal Pulmonary disease

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BLOOD CULTURE; CHILL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; FEVER; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LOBAR PNEUMONIA; MORTALITY; PLEURA FLUID; PROSPECTIVE STUDY; RADIOGRAPHY; RECORDING; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; UREA NITROGEN BLOOD LEVEL; CHILE; COMMUNICABLE DISEASE; COMORBIDITY; FEMALE; IMMUNE DEFICIENCY; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILE; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0142183341     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. VALDIVIA G. Neumonías adquiridas en la comunidad: epidemiología y conceptos generales. Bol Esc Med Univ Católica 1999; 28: 85-91.
2. SKERRET SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999; 20: 531-48.
3. LUNA C, FAMIGLIETTI A, ABSI R, VIDELA AJ, NOGUEIRA FJ, DÍAZ A ET AL. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118: 1344-54.
4. FINE MJ, SMITH MA, CARSON CA, MUTHA SS, SANKEY SS, WEISSFELD LA ET AL. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996; 275: 134-41.
5. AUSTRIAN R, GOLD J. Bacteremia pneumococcal with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-76.
6. MYLOTTE JM, BEAM TR JR. Comparison of community-acquired and nosocomial pneumococcal bacteremia. Am Rev Respir Dis 1981; 123: 265-8.
7. PERLINO CA, RIMLAND D. Alcoholism, leukopenia and pneumococcal sepsis. Am Rev Respir Dis 1985; 132: 757-60.
8. WATANAKUNAKORN C, GREIFENSTEIN A, STROH K, JARJOURA DG, BLEND D, CUGINO A ET AL. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 1993; 103: 1152-6.
9. PALLARES R, LIÑARES J, VADILLO M, CABELLOS C, MANRESA F, VILADRICH PF ET AL. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80.
10. LIPPMANN ML, GOLDBERG SK, WALKENSTEIN MD, HERRING W, GORDON M. Bacteremic pneumococcal pneumonia. A community hospital experience. Chest 1995; 108: 1608-13.
11. TORRES J, CÁRDENAS O, VÁSQUEZ A, SCHLOSSBERG D. Streptococcus pneumoniae bacteremia in a community hospital. Chest 1998; 113: 387-90.
12. EWIG S, RUIZ M, TORRES A, MARCO F, MARTÍNEZ JA, SÁNCHEZ M ET AL. Pneumonia acquired in the community through drug resistant Streptococcus pneumoniae. Am J Respir Crit Care Med 1999; 159: 1835-42.
13. ESPÓSITO A. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. Arch Intern Med 1984; 144: 945-8.
14. WATANAKUNAKORN C, BAILEY TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases. Arch Intern Med 1997; 157: 1965-71.
15. METLAY JP, HOFMANN J, CETRON MS, FINE MJ, FARLEY MM, WHITNEY C ET AL. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520-8.
16. MORONEY JF, FIORE AE, HARRISON LH, PATTERSON JE, FARLEY MM, JORGENSEN JH ET AL. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001; 33: 797-805.
17. ORTQVIST A, GREPE A, JULANDER I, KALIN M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasma pneumonias. Scand J Infect Dis 1988; 20: 163-71.
18. MUSHER DM, ALEXANDRAKI I, GRAVISS EA, YANBEIY N, EID A, INDERIAS LA ET AL. Bacteremic and non-bacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000; 79: 210-21.
19. BREIMAN RF, BUTLER JC, TENOVER FC, ELLIOTT JA, FACKLAM RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831-5.
20. LAGOS R, SAN MARTÍN O, ERAZO A, AVENDAÑO A, LEVINE M Y GRUPO DE TRABAJO COLABORATIVO PARA EL DIAGNÓSTICO DE ENFERMEDADES NEUMOCÓCICAS DEL NIÑO. Epidemiología de las enfermedades invasoras causadas por Streptococcus pneumoniae en niños chilenos: Proyecciones clínicas y de salud pública. Rev Chil Infectol 2001; 18 (suppl 1): 15-21.
21. FEIKIN DR, SCHUCHAT A, KOLCZAK M, BARRET NL, HARRISON LH, LEFKOWITZ L ET AL. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90: 223-9.
22. HENRÍQUEZ A, GONZALEZ P, CONA E, MIRANDA P, MENDOZA J, GIGLIO M ET AL. Diagnóstico etiológico de la neumonía del adulto: utilidad del lavado broncoalveolar. Rev Méd Chile 1991; 119: 758-64.
23. JIMÉNEZ P, SALDÍAS F, MENESES M, SILVA ME, WILSON MG, OTTH L. Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest 1993; 103: 1023-7.
24. FERNÁNDEZ P, SAN MARTÍN L. Neumonía adquirida en la comunidad: Terapia secuencial de cefalosporina intravenosa a cefalosporina oral. Rev Méd Chile 2000; 128: 267-72.
25. DÍAZ A, CALVO M, O'BRIEN A, FARÍAS G, MARDÓNEZ JM, SALDÍAS F. Utilidad clínica de los hemocultivos en pacientes hospitalizados por neumonía adquirida en la comunidad. Rev Méd Chile 2002; 130: 993-1000.
26. FANG GD, FINE M, ORLOFF J, ARISUMI D, YU VL, KAPOOR W ET AL. New emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine (Baltimore) 1990; 69: 307-16.
27. FINE MJ, AUBLE TE, YEALY DM, HANUSA BH, WEISSFEL LA, SINGER DE ET AL. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
28. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Performance Standards for Antimicrobial Susceptibility Testing. 1998; M100-S8 Vol 18 No1.
29. NIEDERMAN MS, BASS JB, CAMPBELL GD, FEIN AM, GROSSMAN RF, MANDELL LA ET AL. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-26.
30. MUFSON MA, KRUSS DM, WASIL RE, METZGER WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 1974; 134: 505-10.
31. HOOK EW III, HORTON CA, SCHABERG DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983; 249: 1055-7.
32. PARKER MM, SHELHAMER JH, BACHARACH SL, GREEN MV, NATANSON C, FREDERICK TM ET AL. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100: 483-90.
33. SOLER T, SALAMANCA L, ARBO G, MOLINA E. Estudio de sensibilidad in vitro de Streptococcus pneumoniae de infecciones respiratorias bajas en el Instituto Nacional del Tórax (INT). Rev Méd Chile 2002; 130: 304-8.
34. SOCIEDAO CHILENA DE ENFERMEDADES RESPIRATORIAS. Consenso Nacional en Neumonías Adquiridas en la Comunidad en Adultos y Niños. Rev Chil Enf Respir 1999; 15: 67-136.
35. NIEDERMAN MS, MANDELL LA, ANZUETO A, BASS JD, BROUGHTON WA, CAMPBELL GD ET AL. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care 2001; 163: 1730-54.
36. SALDÍAS F, MARDÓNEZ J, MARCHESSE M, VIVIANI P, FARÍAS G, DÍAZ A. Cuadro clínico y factores pronósticos en la neumonía adquirida en la comunidad en adultos hospitalizados. Rev Méd Chile 2002; 130: 1373-82.
37. BUTLER JC, SHAPIRO ED, CARLONE GM. Pneumococcal vaccines: History, Current Status and Future Directions. Am J Med 1999; 107 (1A): 69S-76S.